MovDisordV3, Main, Exploration, bibRecord, 003128

Use of nutritional supplements in Parkinson's disease patients

Identifieur interne : 003128 ( Main/Exploration ); précédent : 003127; suivant : 003129

Use of nutritional supplements in Parkinson's disease patients

Auteurs : Summer C. Wolfrath [États-Unis] ; Amy R. Borenstein [États-Unis] ; Skai Schwartz [États-Unis] ; Robert A. Hauser [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Theresa A. Zesiewicz [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2006-08.

RBID : ISTEX:F334D529F67C576E6A3CBD185FF8197FC8ED9D95

Descripteurs français

Pascal (Inist)
- Homme, Parkinson maladie, Système nerveux pathologie, Vitamine.
Wicri :
- topic : Homme, Vitamine.

English descriptors

KwdEn :
- Aged, Dietary Supplements, Female, Herbal Medicine, Human, Humans, Male, Middle Aged, Minerals, Nervous system diseases, Parkinson Disease (therapy), Parkinson disease, Parkinson's disease, Questionnaires, Socioeconomic Factors, Vitamin, Vitamins, nutritional supplements, vitamins.
MESH :
- chemical : Minerals, Vitamins.
- therapy : Parkinson Disease.
- Aged, Dietary Supplements, Female, Herbal Medicine, Humans, Male, Middle Aged, Questionnaires, Socioeconomic Factors.

Abstract

The use of nutritional supplements has almost doubled in the elderly population in the United States (US) in the past decade. We evaluated the use of nutritional supplements in Parkinson's disease (PD) patients to determine the prevalence of their use and whether patients were aware of possible side effects and drug interactions in the supplements they were taking. Consecutively selected PD patients from an academic movement disorders center completed a 33‐item questionnaire regarding their use of nutritional supplements. A total of 120 PD patients completed the questionnaire and were included in the data analysis (mean age ± SD = 68.2 ± 11.65 years, 67 [55.8%] men and 53 women). Seventy‐six patients (63%) took nutritional supplements at the time of data collection. Vitamins were the most common nutritional supplements used, and vitamin E was the most commonly used vitamin. Thirty‐six patients (47%) who took nutritional supplements consulted with their doctor before taking them, and only 4% of patients who took nutritional supplements were aware of possible side effects from their use. Twenty patients (16.7%) reported that they were currently taking nutritional supplements because of symptoms related to their Parkinson's disease. The vast majority of PD patients surveyed were not aware that nutritional supplements could cause adverse side effects. Less than half of the patients who took nutritional supplements consulted their physician before starting them. Greater awareness of nutritional supplement use in PD patients is warranted to avoid potentially harmful effects and drug interactions. © 2006 Movement Disorder Society

Url:

https://api.istex.fr/document/F334D529F67C576E6A3CBD185FF8197FC8ED9D95/fulltext/pdf

DOI: 10.1002/mds.20902

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Use of nutritional supplements in Parkinson's disease patients</title>
<author><name sortKey="Wolfrath, Summer C" sort="Wolfrath, Summer C" uniqKey="Wolfrath S" first="Summer C." last="Wolfrath">Summer C. Wolfrath</name>
</author>
<author><name sortKey="Borenstein, Amy R" sort="Borenstein, Amy R" uniqKey="Borenstein A" first="Amy R." last="Borenstein">Amy R. Borenstein</name>
</author>
<author><name sortKey="Schwartz, Skai" sort="Schwartz, Skai" uniqKey="Schwartz S" first="Skai" last="Schwartz">Skai Schwartz</name>
</author>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
</author>
<author><name sortKey="Sullivan, Kelly L" sort="Sullivan, Kelly L" uniqKey="Sullivan K" first="Kelly L." last="Sullivan">Kelly L. Sullivan</name>
</author>
<author><name sortKey="Zesiewicz, Theresa A" sort="Zesiewicz, Theresa A" uniqKey="Zesiewicz T" first="Theresa A." last="Zesiewicz">Theresa A. Zesiewicz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F334D529F67C576E6A3CBD185FF8197FC8ED9D95</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.20902</idno>
<idno type="url">https://api.istex.fr/document/F334D529F67C576E6A3CBD185FF8197FC8ED9D95/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002411</idno>
<idno type="wicri:Area/Istex/Curation">002411</idno>
<idno type="wicri:Area/Istex/Checkpoint">001B87</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Wolfrath S:use:of:nutritional</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16639735</idno>
<idno type="wicri:Area/PubMed/Corpus">002C74</idno>
<idno type="wicri:Area/PubMed/Curation">002C74</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A36</idno>
<idno type="wicri:Area/Ncbi/Merge">001660</idno>
<idno type="wicri:Area/Ncbi/Curation">001660</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001660</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Wolfrath S:use:of:nutritional</idno>
<idno type="wicri:Area/Main/Merge">004441</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:06-0435075</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001A63</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001258</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001850</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Wolfrath S:use:of:nutritional</idno>
<idno type="wicri:Area/Main/Merge">004945</idno>
<idno type="wicri:Area/Main/Curation">003128</idno>
<idno type="wicri:Area/Main/Exploration">003128</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Use of nutritional supplements in Parkinson's disease patients</title>
<author><name sortKey="Wolfrath, Summer C" sort="Wolfrath, Summer C" uniqKey="Wolfrath S" first="Summer C." last="Wolfrath">Summer C. Wolfrath</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, and Department of Neurology, College of Medicine, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Borenstein, Amy R" sort="Borenstein, Amy R" uniqKey="Borenstein A" first="Amy R." last="Borenstein">Amy R. Borenstein</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Schwartz, Skai" sort="Schwartz, Skai" uniqKey="Schwartz S" first="Skai" last="Schwartz">Skai Schwartz</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, and Department of Neurology, College of Medicine, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Sullivan, Kelly L" sort="Sullivan, Kelly L" uniqKey="Sullivan K" first="Kelly L." last="Sullivan">Kelly L. Sullivan</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, and Department of Neurology, College of Medicine, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Zesiewicz, Theresa A" sort="Zesiewicz, Theresa A" uniqKey="Zesiewicz T" first="Theresa A." last="Zesiewicz">Theresa A. Zesiewicz</name>
<affiliation wicri:level="4"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease and Movement Disorders Center, NPF Center of Excellence, and Department of Neurology, College of Medicine, University of South Florida, Tampa, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-08">2006-08</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1098">1098</biblScope>
<biblScope unit="page" to="1101">1101</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F334D529F67C576E6A3CBD185FF8197FC8ED9D95</idno>
<idno type="DOI">10.1002/mds.20902</idno>
<idno type="ArticleID">MDS20902</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Dietary Supplements</term>
<term>Female</term>
<term>Herbal Medicine</term>
<term>Human</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Minerals</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Questionnaires</term>
<term>Socioeconomic Factors</term>
<term>Vitamin</term>
<term>Vitamins</term>
<term>nutritional supplements</term>
<term>vitamins</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Minerals</term>
<term>Vitamins</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Dietary Supplements</term>
<term>Female</term>
<term>Herbal Medicine</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Questionnaires</term>
<term>Socioeconomic Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Parkinson maladie</term>
<term>Système nerveux pathologie</term>
<term>Vitamine</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Vitamine</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The use of nutritional supplements has almost doubled in the elderly population in the United States (US) in the past decade. We evaluated the use of nutritional supplements in Parkinson's disease (PD) patients to determine the prevalence of their use and whether patients were aware of possible side effects and drug interactions in the supplements they were taking. Consecutively selected PD patients from an academic movement disorders center completed a 33‐item questionnaire regarding their use of nutritional supplements. A total of 120 PD patients completed the questionnaire and were included in the data analysis (mean age ± SD = 68.2 ± 11.65 years, 67 [55.8%] men and 53 women). Seventy‐six patients (63%) took nutritional supplements at the time of data collection. Vitamins were the most common nutritional supplements used, and vitamin E was the most commonly used vitamin. Thirty‐six patients (47%) who took nutritional supplements consulted with their doctor before taking them, and only 4% of patients who took nutritional supplements were aware of possible side effects from their use. Twenty patients (16.7%) reported that they were currently taking nutritional supplements because of symptoms related to their Parkinson's disease. The vast majority of PD patients surveyed were not aware that nutritional supplements could cause adverse side effects. Less than half of the patients who took nutritional supplements consulted their physician before starting them. Greater awareness of nutritional supplement use in PD patients is warranted to avoid potentially harmful effects and drug interactions. © 2006 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Floride</li>
</region>
<settlement><li>Tampa</li>
</settlement>
<orgName><li>Université de Floride du Sud</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Floride"><name sortKey="Wolfrath, Summer C" sort="Wolfrath, Summer C" uniqKey="Wolfrath S" first="Summer C." last="Wolfrath">Summer C. Wolfrath</name>
</region>
<name sortKey="Borenstein, Amy R" sort="Borenstein, Amy R" uniqKey="Borenstein A" first="Amy R." last="Borenstein">Amy R. Borenstein</name>
<name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
<name sortKey="Schwartz, Skai" sort="Schwartz, Skai" uniqKey="Schwartz S" first="Skai" last="Schwartz">Skai Schwartz</name>
<name sortKey="Sullivan, Kelly L" sort="Sullivan, Kelly L" uniqKey="Sullivan K" first="Kelly L." last="Sullivan">Kelly L. Sullivan</name>
<name sortKey="Zesiewicz, Theresa A" sort="Zesiewicz, Theresa A" uniqKey="Zesiewicz T" first="Theresa A." last="Zesiewicz">Theresa A. Zesiewicz</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003128 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003128 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F334D529F67C576E6A3CBD185FF8197FC8ED9D95
   |texte=   Use of nutritional supplements in Parkinson's disease patients
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Use of nutritional supplements in Parkinson's disease patients

Use of nutritional supplements in Parkinson's disease patients

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.